Browse by all authors Browse By Author Name - Ansari,+A

Browse Results (8 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Ansari, A., Aslam, Z., De Sica, A., Smith, M., Gilshenans, K., Fairbanks, L., Marinaki, A., Sanderson, J. and Duley, J. (2008) Influence of xanthine oxidase on thiopurine metabolism in Crohn's disease. Alimentary Pharmacology & Therapeutics, 28 6: 749-757. doi:10.1111/j.1365-2036.2008.03768.x 71   17 Cited 19 times in Scopus19 0
Ansari, A., Elliott, B., Baburajan, B., Mayhead, P., O'Donohue, J., Chocair, P., Sanderson, J. and Duley, J. (2008) Long-term outcome of using allopurinol co-therapy as a strategy for overcoming thiopurine hepatotoxicity in treating inflammatory bowel disease. Alimentary Pharmacology & Therapeutics, 28 6: 734-741. doi:10.1111/j.1365-2036.2008.03782.x 103   51 Cited 57 times in Scopus57 0
Ansari, A., Patel, N., Sanderson, J., O'Donohue, J., Duley, J. and Florin, T. H. J. (2010) Low-dose azathioprine or mercaptopurine in combination with allopurinol can bypass many adverse drug reactions in patients with inflammatory bowel disease. Alimentary Pharmacology and Therapeutics, 31 6: 640-647. doi:10.1111/j.1365-2036.2009.04221.x 126   49 Cited 53 times in Scopus53 5
Smith, M. A., Marinaki, A. M., Arenas, M., Shobowale-Bakre, M., Lewis, C. M., Ansari, A., Duley, John and Sanderson, J. D. (2009) Novel pharmacogenetic markers for treatment outcome in azathioprine-treated inflammatory bowel disease. Alimentary Pharmacology and Therapeutics, 30 4: 375-384. doi:10.1111/j.1365-2036.2009.04057.x 60   38 Cited 43 times in Scopus43 3
Ansari, A., Arenas, M., Greenfield, S. M., Morris, D., Lindsay, J., Gilshenan, K., Smith, M., Lewis, C., Marinaki, A., Duley, J. and Sanderson, J. (2008) Prospective evaluation of the pharmacogenetics of azathioprine in the treatment of inflammatory bowel disease. Alimentary Pharmacology & Therapeutics, 28 8: 973-983. doi:10.1111/j.1365-2036.2008.03788.x 58   71 Cited 80 times in Scopus80 0
Pavlidis, P., Ansari, A., Duley, J., Oancea, I. and Florin, T. (2014). Splitting the normal daily dose of thioguanine may be efficacious treatment for inflammatory bowel diesease and avoid hepatic toxicity. In: Abstracts: British Society of Gastroenterology Annual General Meeting. British Society of Gastroenterology Annual General Meeting, Manchester Central, United Kingdom, (A164-A165). 16 - 19 June 2014. doi:10.1136/gutjnl-2014-307263.353 14   0
Sheikh, M., Nelson-Piercy, C., Stenner, J., Mackenzie, G., Duley, J., Florin, T. and Ansari, A. (2014). Successful pregnancies with thiopurine-allopurinol co-therapy for inflammatory bowel disease. In: Abstracts: British Society of Gastroenterology Annual General Meeting. British Society of Gastroenterology Annual General Meeting, Manchester Central, United Kingdom, (A85-A86). 16 - 19 June 2014. doi:10.1136/gutjnl-2014-307263.180 17 10 0
Duley, J., Ansari, A., Aslam, A., Smith, M., De Sica, A., Fairbanks, L.D., Marinaki, A. M. and Sanderson, J. (2007). Xanthine Oxidase Metabolism of Azathioprine In IBD Patients. In: C. G. Sobey and S. Smid, 41st Annual Scientific Meeting of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists and 10th Southeast Asian Western Pacific Regional Meeting of Pharmacologists, Adelaide South Australia, (Poster 3 - 77-Poster 3 - 77). 2nd - 6th December, 2007. 86